Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications
Author:
Funder
Arnold Ventures
Publisher
Elsevier BV
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference23 articles.
1. The high cost of prescription drugs in the United States;Kesselheim;JAMA,2016
2. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers;Carlson;Health Policy,2010
3. Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold;Neumann;N Engl J Med,2014
4. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement;Neumann;Health Aff,2011
5. Performance-based risk-sharing arrangements for pharmaceutical products in the United States: a systematic review;Yu;J Manag Care Spec Pharm,2017
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process;Value in Health;2023-01
2. A Scoping Review Investigating the Use of Outcome-based Models to Improve Healthcare Outcomes and Reduce Healthcare Spending;2022 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM);2022-12-07
3. Is There a Future for Value-Based Contracting?;Value in Health;2020-04
4. Outcomes-based diabetes drug pricing may not lower costs;PharmacoEconomics & Outcomes News;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3